Featuring Rene Quashie, Senior Counsel, Epstein, Becker & Green; and Jeff Rowes, Senior Attorney, Institute for Justice; with a response from Josh Sharfstein, Associate Dean, Johns Hopkins Bloomberg School of Public Health; moderated by Simon Lester, Trade Policy Analyst, Cato Institute.
A limited constitutional government calls for a rules-based, freemarket monetary system, not the topsy-turvy fiat dollar that now exists under central banking. This issue of the Cato Journal examines the case for alternatives to central banking and the reforms needed to move toward free-market money.
Two long wars, chronic deficits, the financial crisis, the costly drug war, the growth of executive power under Presidents Bush and Obama, and the revelations about NSA abuses, have given rise to a growing libertarian movement in our country – with a greater focus on individual liberty and less government power. David Boaz’s newly released The Libertarian Mind is a comprehensive guide to the history, philosophy, and growth of the libertarian movement, with incisive analyses of today’s most pressing issues and policies.
In the affirmative, Roger Pilon,
Vice President for Legal Affairs, Cato Institute; in the negative, John E. Calfee,
Resident Scholar, American Enterprise Institute.
In this election year, the drug reimportation debate is heating up. Last year the House easily passed a bill that would allow Americans to buy prescription drugs abroad, where they sell at far below American prices, but the bill stalled in the Senate. This year pressure is building from governors, mayors, and ordinary citizens, many of whom are simply ignoring the current ban on importing drugs. Proponents of the bill say that free trade is likely to reduce the high prices Americans now pay for prescription drugs. Opponents raise safety concerns and add that the bill would amount to importing foreign price controls. Please join us for a timely debate on an issue that touches millions of Americans.